Royal Bank of Canada’s Cytek Biosciences CTKB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10K	Sell	2,299 -3,226	-58%	-$15.2K	﹤0.01%	6152
2025 Q4	$28K	Buy	5,525 +1,403	+34%	+$6.51K	﹤0.01%	5859
2025 Q3	$15K	Sell	4,122 -18,326	-82%	-$68.8K	﹤0.01%	6336
2025 Q2	$76K	Buy	22,448 +2,991	+15%	+$9.97K	﹤0.01%	5741
2025 Q1	$78K	Sell	19,457 -4,074	-17%	-$21.1K	﹤0.01%	5352
2024 Q4	$152K	Buy	23,531 +11,343	+93%	+$67.6K	﹤0.01%	5042
2024 Q3	$68K	Buy	12,188 +771	+7%	+$4.37K	﹤0.01%	5556
2024 Q2	$64K	Buy	11,417 +7,203	+171%	+$43.3K	﹤0.01%	5527
2024 Q1	$28K	Sell	4,214 -36,484	-90%	-$289K	﹤0.01%	5772
2023 Q4	$371K	Buy	40,698 +25,140	+162%	+$158K	﹤0.01%	4539
2023 Q3	$86K	Buy	15,558 +8,036	+107%	+$64.5K	﹤0.01%	5475
2023 Q2	$64K	Buy	7,522 +1,078	+17%	+$9.67K	﹤0.01%	5648
2023 Q1	$60K	Sell	6,444 -14,221	-69%	-$153K	﹤0.01%	5523
2022 Q4	$212K	Buy	20,665 +18,591	+896%	+$250K	﹤0.01%	4824
2022 Q3	$30K	Buy	2,074 +1,430	+222%	+$18.6K	﹤0.01%	5975
2022 Q2	$7K	Sell	644 -5,351	-89%	-$53.3K	﹤0.01%	6511
2022 Q1	$65K	Buy	5,995 +2,341	+64%	+$31.6K	﹤0.01%	5918
2021 Q4	$59K	Buy	3,654 +1,811	+98%	+$37.9K	﹤0.01%	6278
2021 Q3	$40K	Buy	+1,843	New	+$43.4K	﹤0.01%	6289